Figure 1From: Efficacy of pegylated interferon α2a in patients without HBeAg loss after the withdrawal of long-term lamivudine therapyStudy design. Liver function was tested 4-weekly within 24 weeks of lamivudine withdrawal and 12-weekly after 24 weeks of lamivudine withdrawal. ALT: alanine aminotransferase; ULN: upper limit of normal; IFN: interferon; T-Bil: total bilirubin; LAM: lamivudine.Back to article page